Acadia Healthcare Company, Inc. current report, 23 May 2013

Acadia Healthcare Company, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K covers events occurring on May 23, 2013, regarding the Company's 2013 Annual Meeting of Stockholders. The report details the election of directors, the approval of an amended incentive compensation plan, and advisory votes on executive compensation.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and stockholder voting outcomes rather than financial performance.

Material Changes and Voting Results

Significant corporate actions approved by stockholders include:

  • Director Elections: Four Class II directors were elected to serve until 2016. Voting results varied significantly among candidates:
    • William F. Grieco: 42,374,980 For; 1,950,729 Withheld.
    • Joey A. Jacobs: 37,273,776 For; 7,051,933 Withheld.
    • Kyle D. Lattner: 34,175,518 For; 10,150,191 Withheld.
    • Reeve B. Waud: 24,985,750 For; 19,339,959 Withheld.
  • Incentive Compensation Plan: Stockholders approved the Amended and Restated Incentive Compensation Plan. This amendment increases the aggregate number of shares available for awards by 2,000,000. The vote was 42,519,145 For versus 1,801,935 Against.
  • Executive Compensation Advisory Vote: Stockholders approved the compensation of Named Executive Officers (42,347,740 For vs. 1,971,606 Against).
  • Compensation Vote Frequency: Stockholders voted to conduct the advisory vote on executive compensation annually (24,958,228 votes for 1 Year vs. 17,949,892 for 3 Years).
  • Auditor Ratification: Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2013 (46,543,696 For vs. 190,910 Against).

Guidance, Outlook, and Risks

The filing does not contain management guidance, financial outlook, or specific risk factors. The primary focus is the administrative outcome of the Annual Meeting. The Board determined that future advisory votes on executive compensation will occur annually based on the stockholder vote.

Key Facts for Investor Verification

  • Verify the specific terms of the Amended and Restated Incentive Compensation Plan, particularly the 2,000,000 share increase, in the Definitive Proxy Statement filed April 30, 2013.
  • Note the significant number of withheld votes for directors Kyle D. Lattner and Reeve B. Waud, indicating potential stockholder dissatisfaction with these specific nominees.
  • Confirm the Board's commitment to annual executive compensation advisory votes as mandated by the stockholder preference.
  • Review the full text of the Incentive Compensation Plan (Exhibit 10) for details on administration changes referenced in the filing.